Low-dose intravenous azathioprine may be effective in the management of acute fulminant colitis complicating inflammatory bowel disease

Alimentary Pharmacology and Therapeutics

Volumn 13, Issue 7, 1999, Pages 891-895

  Casson, D H ^a   Davies, S E ^b   Thomson, M A ^a   Lewis, A ^c   Walker Smith, J A ^a   Murch, S H ^a,c  

^a Royal Free Campus   (United Kingdom)

^b Great Ormond Street Hospital for Children   (United Kingdom)

^c ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE;

ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL TRIAL; COLITIS; CROHN DISEASE; DRUG EFFICACY; ENTERITIS; FEMALE; GASTROINTESTINAL ENDOSCOPY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; ORAL DRUG ADMINISTRATION; PATIENT MONITORING; PRIORITY JOURNAL; SCHOOL CHILD; ULCERATIVE COLITIS;

EID: 0032998030     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.1999.00559.x     Document Type: Article

References (29)

1. Truelove SC, Willoughby Lee EG, Kettlewell MG. Further experience in the treatment of severe attacks of ulcerative colitis. Lancet 1978; ii: 1086-8.
2. Marion JF, Present DH. The modern medical management of acute, severe ulcerative colitis. Eur J Gastroenterol Hepatol 1997; 9; 831-5.
3. Lennard Jones JE. Defining ulcer depth in colitis. Lancet 1996; 347: 1708.
4. Murch SH, Walker-Smith JA. Medical therapy of chronic inflammatory bowel disease. Baillièbre's Clin Gastroenterol 1994; 8: 133-48.
5. Sandborn WJ. A review of immune modifier therapy for inflammatory bowel disease: azathioprine 6-mercaptopurine, cyclosporine, and methotrexate. Am J Gastroenterol 1996; 91: 423-33.
6. Markowitz J, Grancher K, Mandel F, Daum F. Immunosuppressive therapy in pediatric inflammatory bowel disease: results of a survey of the North American Society for Pediatric Gastroenterology and Nutrition. Subcommittee on Immunosuppressive use of the Pediatric IBD Collaborative Research Forum. Am J Gastroenterol 1993; 88: 44-8.
7. D'Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology 1997; 112: 1475-81.
8. Bouhnik Y, Lemann M, Mary JY, et al. Long-term follow-up of patients with Crohn's disease treated with azathioprine or 6-mercaptopurine. Lancet 1996; 347: 215-9.
9. Mahdi G, Israel DM, Hassall E. Cyclosporine and 6-mercaptopurine for active, refractory Crohn's colitis in children. Am J Gastroenterol 1996; 91: 1355-9.
10. Rhodes J, Bainton D, Beck P, Campbell H. Controlled trial of azathioprine in Crohn's disease. Lancet 1971; ii: 1273-6.
11. Summers RW, Switz DM, Sessions JT Jr, et al. National Cooperative Crohn's Disease Study: results of drug treatment. Gastroenterology 1979; 77: 847-69.
12. Ewe K, Press AG, Singe CC, et al. Azathioprine combined with prednisolone or monotherapy with prednisolone in active Crohn's disease. Gastroenterology 1993; 105: 367-72.
13. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, double blind study. New Engl J Med 1980; 302: 981-7.
14. Pearson DC, May GR, Fick GH, Sutherland LR. Azathioprine in Crohn's disease. A meta-analysis. Ann Int Med 1995; 122: 132-42.
15. Van Sandborn WJOEC, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease. Gastroenterology 1995; 109: 1808-17.
16. Cuffari C, Theoret Y, Latour S, Seidman G. 6-mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut 1996; 39: 401-6.
17. Sandborn WJ. Selected Summaries. Comment on Cuffari C, Theoret Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut 1996; 39: 401-6. Gastroenterology 1997; 113: 690-2.
18. Sandborn WJ. Selected Summaries. Comment on Cuffari C, Theoret Y, Latour S, Seidman G. 6-Mercaptopurine metabolism in Crohn's disease: correlation with efficacy and toxicity. Gut 1996; 39: 401-6. Gastroenterology 1997; 113: 690-2.
19. Kerstens PJSM, Stolk JN, Boerbooms AMT, De Abreu RA, Van De Putte LBA. Purine enzymes in rheumatoid arthritis. A clue to the prediction of the response to azathioprine? review and hypothesis. Clin Exp Rheumatol 1995; 13: 107-11.
20. Candy S, Wright J, Gerber M, Adams G, Gerig M, Goodman R. A controlled double blind study of azathioprine in the management of Crohn's disease. Gut 1995; 37: 674-8.
21. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT. Serum concentrations of tumour necrosis factor-alpha in childhood chronic inflammatory bowel disease. Gut 1991; 32: 913-7.
22. Alamartine E, Sabido O, Berthoux F. In-vitro effects of cyclosporin A, FK506, 6-mercaptopurine and prednisolone on lymphokine-activated killer cells. Nephrol Dialys Transplant 1994; 9: 1456-61.
23. Calne RY, Alexander GPJ, Murray JE. A study of the effects of drugs in prolonging survival of homologous renal transplants in dogs. Ann NY Acad Sci 1962; 99: 743-61.
24. Kretensky TA, Hall WW, Selph JL, Truax JF, Vinegar R. Nucleosides of azathioprine and thiamiprine as antiarthritics. J Med Chem 1989; 32: 1471-5.
25. Crawford DJ, Maddocks JL, Jones DN, Szawlowski P. Rational design of novel immunosuppressive drugs: analogues of azathioprine lacking the 6-mercaptopurine substituent retain or have enhanced immunosuppressive effects. J Med Chem 1996; 39: 2690-5.
26. Beattie RM, Nicholls SW, Domizio P, Williams CB, Walker-Smith JA. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Paediatr Gastroenterol Nutr 1996; 22: 373-9.
27. Modigliani R, Mary JY, Simon JF, Cortot a Soule JC, Gendre JP, Rene E. Clinical biological and endoscopic picture or attacks of Crohn's disease. Evolution on prednisolone. Gastroenterology 1990; 98: 811-8.
28. D'Haens G, Geboes K, Ponette E, Penninckx F, Rutgeerts P. Healing of severe recurrent ileitis with azathioprine therapy in patients with Crohn's disease. Gastroenterology 1997; 112: 1475-81.
29. Walker-Smith JA. Mucosal healing in Crohn's disease. Gastroenterology 1998; 114: 419-20.